A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor.
Ryu MH, Kang WK, Bang YJ, Lee KH, Shin DB, Ryoo BY, Roh JK, Kang JH, Lee H, Kim TW, Chang HM, Park JO, Park YS, Kim TY, Kim MK, Lee WK, Kang HJ, Kang YK.
Ryu MH, et al. Among authors: ryoo by.
Oncology. 2009;76(5):326-32. doi: 10.1159/000209384. Epub 2009 Mar 23.
Oncology. 2009.
PMID: 19307738
Clinical Trial.